GWU’s covid-19 clinical trial has met one early goal — getting Black and Latino people to join

A critical goal for the Phase 3 clinical trial is also to ensure that the pool of the vaccine test subjects reflects the nation’s diversity, including minorities, older Americans and people with preexisting health conditions. It’s all the more important given the disparate impact the pandemic has had on people who are Black or Latino, as well as other racial minorities.